Exabis Library
Welcome to the e-CCO Library!
P072: Quantitative phase imaging for the characterisation of Crohn’s disease-derived intestinal strictures
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P072: Safety analysis of vedolizumab during pregnancy: Findings from a reproductive study in monkeys
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P072: The involvement of extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) and Nicotinate Phosphoribosyltransferase (eNAPRT) in inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P072: The role of the rs8005161 polymorphism on pH-sensing G protein-coupled receptor GPR65 (TDAG8) signalling in intestinal inflammation
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P072: TREM-1 stimulation ameliorates colitis in mice
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P073 Compartmentalised human gut immunity: studies of innate and adaptive lymphocyte distribution in the epithelium, lamina propria and GALT of healthy gut mucosa by flow cytometry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0730: Inflammatory Bowel Disease Lifestyle Food and Exercise (IBDLiFE) study: a randomized controlled trial to investigate the effectiveness of a personalised diet and physical activity intervention for adults with inactive IBD in Aotearoax7x7x7 New Zealand
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0731: Analysis of the short-term efficacy and risk factors of ustekinumab combined with surgical intervention in the management of perianal fistulizing Crohn's Disease: a single center real-world result
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0732: A cost comparison of treatment sequencing for Ulcerative Colitis: vedolizumab vs ustekinumab as a second-line biologic in anti-TNF-exposed patients in Canada
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0733: REALASA: Real-world effectiveness assessment of first-line 5-ASA for the treatment of Ulcerative Colitis in Sweden
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0734: Real-World Experience of Curcumin+Qing Dai Reduces Biochemical and Intestinal Ultrasound Disease Markers in Patients with Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0735: Early dietetic assessment predicts clinical efficacy of Exclusive Enteral Nutrition in adults with Crohn’s disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0736: Analysis of endoscopic recurrence risk factors in Crohn's disease after surgical treatment within 1 year
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0738: Apulian Network for Inflammatory Bowel Disease (AN-IBD) safety profile: Pilot data
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0739: Treatment persistencex7x7x7 clinicalx7x7x7 and biological outcomes following an elective switch from intravenous to subcutaneous infliximab and vedolizumab
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P073: Age dependent decrease in gut-homing CD4 lymphocytes
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P073: An increased autophagy and decreased apoptosis is detected in intestinal fibroblasts from Crohn’s Disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P073: Changes in gut microbial signatures differentiate behavioural Crohn’s disease phenotypes; an in silico approach
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P073: Eosinophil depletion partially protects from colonic inflammation, but increases colonic collagen deposition in a DSS colitis model
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P073: Evaluation of DPPH free radical scavenging activity by HPLC technique: a screening method for drugs and nutrients used in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM